Abilify vs Rexulti

This forum made possible through the generous support of SDN members, donors, and sponsors. Thank you.

LoKoTe

Full Member
15+ Year Member
Joined
Apr 5, 2007
Messages
366
Reaction score
8
Rexulti is been around almost a year already. Have you seen any benefits in real life compared to Abilify? Thanks.


Sent from my iPhone using SDN mobile app

Members don't see this ad.
 
Members don't see this ad :)
Sigh. Don't put me on any marketing focus groups. Rereading my post, I've already realized that "Longlasta" rolls off the tongue much more easily.
 
Just saw a patient with Bordeline PD who had a two week trail of Rexulti samples and then insurance wouldn't cover. They are convinced that it is the only medication that has ever worled for them after being tried on countless others for their "really bad Bipolar". Apparently it has a robust placebo effect, especially when given to a class of patients with a robust placebo response. Then you couple that with a prohibition effect and you have a miracle drug.
 
Last edited:
Just saw a patient with Bordeline PD who had a two week trail of Rexulti samples and then insurance wouldn't cover. They are convinced that it is the only medication that has ever worled for them after being tried on countless others for their really bad Bipolar. Apparently it has a robust placebo effect, especially when given to a class of patients with a robust placebo response. Then you couple that with a prohibition effect and you have a miracle drug.

Rexults are rexults . . .
 
Gave out samples two 5 patients. Four of them did well. Insurance coverage is a big issue.
 
it is interesting how we keep getting more and more antipsychotics being prescribed more and more broadly. Meanwhile my friend who has schizophrenia is frustrated because nothing has really ever been better for him than zyprexa and he still hears voices and has delusional beliefs. Meanwhile he struggles with weight gain, experiences sedation, has constant thirst, and some impairment in cognition. He has an extremely high IQ and is connected to a very strong supportive network so is able to reason this stuff out fairly well compared to the majority of the patients I have known with schizophrenia. One thing he said to me was that the medication is like a shotgun targeting things throughout his brain and what he really needs is someone to develop a medication that is more like a sniper rifle that targets the part of his brain that malfunctions. Pretty insightful for someone who doesn't know any neurobiology. He might even try this Rexulti and probably be disappointed yet again because the marketing is way ahead of the science.
 
It is kind of sad when we actually have no idea whether this medication is really going to help people more than any other psychotropic medication. I wasn't nearly so cynical about medications when I first got into the field almost 15 years ago because there was still some excitement about some of the new medications coming online.
 
it is interesting how we keep getting more and more antipsychotics being prescribed more and more broadly. Meanwhile my friend who has schizophrenia is frustrated because nothing has really ever been better for him than zyprexa and he still hears voices and has delusional beliefs. Meanwhile he struggles with weight gain, experiences sedation, has constant thirst, and some impairment in cognition. He has an extremely high IQ and is connected to a very strong supportive network so is able to reason this stuff out fairly well compared to the majority of the patients I have known with schizophrenia. One thing he said to me was that the medication is like a shotgun targeting things throughout his brain and what he really needs is someone to develop a medication that is more like a sniper rifle that targets the part of his brain that malfunctions. Pretty insightful for someone who doesn't know any neurobiology. He might even try this Rexulti and probably be disappointed yet again because the marketing is way ahead of the science.[/QUOTE

It's more than just marketing though. It's not like the Rexulti reps are doing anything clever or unique. It's simply a function of the system being broken.....namely, why should medicaid/medicare EVER pay for a drug like Rexulti? That is so absurd on so many levels.

The question we should all be asking is- how many of my patients that have a longstanding dx of a psychotic d/o are being helped by their meds? And how could we work on better identifying those patients? And even amongst those patients, how long should we treat for? Yes, I know there is a bunch of work towards those questions now(at least one of them), but there really is no concensus standard of care.
 
I hate it when I ruin the quote thing while editing. 🙂
People like to give you a hard time on this board, but those are some of the key questions we need to ask. Especially interesting to me has always been the question of long term outcomes with long term use of medications. More specifically, should we treat episodic illnesses with stable medication regimens? There is some evidence out there that indicates decreasing medication should be a goal, but that is not how we tend to approach it. I understand why we do this since the impact of serious mental illness can be dramatic and if you decrease a medication and patient goes off the deep end and something bad happens, you look a lot worse than if you had kept the dosage stable. Patients can be reluctant to try titrating off a medication and when they do, they tend to do it too abruptly instead of following sound advice. People are impatient and like to go from one extreme to the other.
 
Top